Ironwood Pharmaceuticals

$11.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+1.72%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell IRWD and other stocks, options, and ETFs commission-free!

About IRWD

Ironwood Pharmaceuticals, Inc. Class A Common Stock, also called Ironwood Pharmaceuticals, is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA. The listed name for IRWD is Ironwood Pharmaceuticals, Inc. Class A Common Stock.

CEO
Mark Mallon
Employees
317
Headquarters
Boston, Massachusetts
Founded
1998
Market Cap
1.89B
Price-Earnings Ratio
16.99
Dividend Yield
Average Volume
1.01M
High Today
$11.83
Low Today
$11.55
Open Price
$11.63
Volume
534.93K
52 Week High
$14.10
52 Week Low
$7.99

Collections

IRWD Earnings

-$0.26
-$0.04
$0.18
$0.40
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 11, After Hours

You May Also Like